Home » Jazz Pharma Agrees to Sell Women’s Health Business
Jazz Pharma Agrees to Sell Women’s Health Business
The Irish drugmaker Jazz Pharmaceuticals is selling its women’s health business to specialty pharmaceutical company Meda for $95 million in cash so that it can concentrate on its core products.
Businessweek
Businessweek
Upcoming Events
-
07May
-
14May
-
30May